(Q38262105)

1 September 2017

1 reference

title

Renin-angiotensin system within the diabetic podocyte (English)

1 reference

1 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Eva Márquez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Julio Pascual

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

María José Soler

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

1 reference

22 October 2014

1 reference

American Journal of Physiology - Renal Physiology

1 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

F1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

c-Abl mediates angiotensin II-induced apoptosis in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II induces apoptosis in rat glomerular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Activation of a local tissue angiotensin system in podocytes by mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Activation of a local renin angiotensin system in podocytes by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Telmisartan inhibits AGE-induced podocyte damage and detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Mechanisms of angiotensin II signaling on cytoskeleton of podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

The (pro)renin receptor and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Redox dependence of glomerular epithelial cell hypertrophy in response to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Functional expression of the renin-angiotensin system in human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via the ERK1/2 MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

The podocyte as a target for therapies--new and old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Big angiotensin-25: a novel glycosylated angiotensin-related peptide isolated from human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Podocyte loss and progressive glomerular injury in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Reversibility of structural and functional damage in a model of advanced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Network modeling reveals steps in angiotensin peptide processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Ameliorative potential of angiotensin1-7/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

The podocyte in diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Enzymatic processing of angiotensin peptides by human glomerular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Characterization of angiotensin II-receptor subtypes in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Vitamin D receptor signaling in podocytes protects against diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Podocyte number in normotensive type 1 diabetic patients with albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Urine podocyte mRNAs mark progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Activation of the renin-angiotensin system within podocytes in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Inhibition of nephrin activation by c-mip through Csk-Cbp-Fyn axis plays a critical role in Angiotensin II-induced podocyte damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00531.2013

10.1152/AJPRENAL.00531.2013

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25339703%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference